cannabidiol - Page 1 | CARLAT PUBLISHING

4 Rationalizations for Cannabis Use—And How to Respond

May 26, 2025

Daniel Carlat, MD

Expert Q&A

Cannabis Use for Managing Agitation in Dementia

January 1, 2024

Aaron Greenstein, MD.

Aaron Greenstein, MD.

Geriatric psychiatrist in private practice, Denver, CO. Dr. Greenstein is a medical advisor for BrainCheck, Sensi.AI, and Optimize VBC. He is a consultant for GE Healthcare and LEK Consulting.

Relevant financial relationships listed for the author have been mitigated.

Dr. Aaron Greenstein describes when to use dronabinol and dispensary cannabis products for treating agitation in dementia.

Can CBD Work for PTSD?

September 25, 2022

Sin Yan Lo, PMHNP-BC

Sin Yan Lo, PMHNP-BC. Ms. Lo, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Cannabidiol (CBD oil) is a popular self-remedy for anxiety and insomnia. A new study tests the drug in PTSD.

Cannabidiol for Crack-Cocaine Craving: Negative Findings

July 3, 2021

David Moltz, MD

David Moltz, MD Dr. Moltz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Cocaine use disorder is notoriously difficult to treat. The authors of this study asked, might cannabidiol be helpful in treating the cravings that prompt cocaine use? While this might seem like an unusual question at first, there is some supportive preclinical data that makes the premise plausible. Unfortunately, the results were negative in this small study.

Is There a Case for Cannabis in the Treatment of Pain?

August 30, 2019

Adrienne Grzenda, MD, PhD.

Adrienne Grzenda, MD, PhD. Dr. Grzenda has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Many patients report that marijuana improves their pain. Their experience has a grain of truth to it, but not enough to classify cannabis as an analgesic.

Prescription CBD Is Available, But Are We Ready to Use It?

January 1, 2019

Chris Aiken, MD

Chris Aiken, MD Editor-in-Chief of The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Your patient comes in with a new medication on his list: CBD oil. He started taking it for anxiety and wants to know if it’s safe. You hedge, explaining that there is limited information available on unregulated products, but the patient is persistent. He says CBD oil is available as a prescription, and wonders if you could write one for it.

Cannabidiol for Schizophrenia

January 1, 2019

Michael Posternak, MD.

Michael Posternak, MD. Dr. Posternak has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this pilot study, investigators evaluated the benefits of cannabidiol (CBD), which is one of the two main active components of marijuana (the other being THC), for the treatment of schizophrenia.